Study of adults with hepatitis D and hepatitis B coinfection
Part of Digestive system, Infections clinical trials.
This study follows adults who have ongoing hepatitis D infection along with hepatitis B. It aims to better understand this mixed infection and how these patients do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years
- You must have a chronic hepatitis D infection (a positive blood test for hepatitis D)
- You must also be living with hepatitis B (the study is for hepatitis B and D together)
- You must be able to give written informed consent before any study procedures
- You must be covered by French health insurance or eligible for medical aid (Aide Médicale d'Etat)
- You cannot be in another biomedical research study that still has a “no-enrollment” period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called Hepalatide for people with chronic hepatitis D, a serious liver infection. It aims to see if the drug can reduce the virus and improve liver health. You may be eligible if you have both hepatitis B and D and are on stable hepatitis B treatment.
This “real-life” study follows people with chronic hepatitis B to better understand their health over time. It may help researchers learn which factors affect outcomes in everyday care.
This study looks at mouth health in people with hepatitis B and D, including those taking a medicine called bulevirtide and those not taking it. It may help understand how these infections affect the mouth and gums.
This study looks at patient information (your health data) for adults who test positive for HDV. You may help researchers better understand HDV by allowing their team to collect and use your data.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study tests whether people with both HIV and chronic hepatitis B should be checked for a third liver virus called HDV (hepatitis D). It helps find hidden infections so they can get the right care.
Hear when a new Hepatitis D, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.